Evidence map›Paper›PMID 26987475›Full record

ArticleScientific reports2016

Contrast-enhanced optical coherence tomography with picomolar sensitivity for functional in vivo imaging.

Orly Liba, Elliott D SoRelle, Debasish Sen, Adam de la Zerda

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. In vivo optical molecular imaging of inflammation and immunity.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Orly LibaMolecular Imaging Program at Stanford, Stanford University, 299 Campus Drive, Stanford, California 94305, USA.
Elliott D SoRelleMolecular Imaging Program at Stanford, Stanford University, 299 Campus Drive, Stanford, California 94305, USA.
Debasish SenMolecular Imaging Program at Stanford, Stanford University, 299 Campus Drive, Stanford, California 94305, USA.
Adam de la ZerdaMolecular Imaging Program at Stanford, Stanford University, 299 Campus Drive, Stanford, California 94305, USA.

Funding

Pilot ProjectsU54CA151459 · NCI · STANFORD UNIVERSITY · PI GAMBHIR, SANJIV S · 2010 to 2014
$12.6M
Molecular Biophysics Training Program at StanfordT32GM008294 · NIGMS · STANFORD UNIVERSITY · PI HUANG, KERWYN C. · 1989 to 2019
$7.4M
Molecular Imaging of Protein Glycosylation in Living SubjectsDP5OD012179 · OD · STANFORD UNIVERSITY · PI DE LA ZERDA, ADAM · 2012 to 2016
$2.0M
NCCDPHP CDC HHS DP50D012179NCI NIH HHS U54 CA151459NCI NIH HHS U54CA151459NCRR NIH HHS 1S10RR026780001NIGMS NIH HHS T32 GM008294NIGMS NIH HHS T32 GM-08294NIH HHS DP5 OD012179
6 · The paper itself

Abstract

Optical Coherence Tomography (OCT) enables real-time imaging of living tissues at cell-scale resolution over millimeters in three dimensions. Despite these advantages, functional biological studies with OCT have been limited by a lack of exogenous contrast agents that can be distinguished from tissue. Here we report an approach to functional OCT imaging that implements custom algorithms to spectrally identify unique contrast agents: large gold nanorods (LGNRs). LGNRs exhibit 110-fold greater spectral signal per particle than conventional GNRs, which enables detection of individual LGNRs in water and concentrations as low as 250 pM in the circulation of living mice. This translates to ~40 particles per imaging voxel in vivo. Unlike previous implementations of OCT spectral detection, the methods described herein adaptively compensate for depth and processing artifacts on a per sample basis. Collectively, these methods enable high-quality noninvasive contrast-enhanced imaging of OCT in living subjects, including detection of tumor microvasculature at twice the depth achievable with conventional OCT. Additionally, multiplexed detection of spectrally-distinct LGNRs was demonstrated to observe discrete patterns of lymphatic drainage and identify individual lymphangions and lymphatic valve functional states. These capabilities provide a powerful platform for molecular imaging and characterization of tissue noninvasively at cellular resolution, called MOZART.

Indexed as

AlgorithmsAnimalsContrast MediaDiagnostic ImagingGoldMiceNanotubesSensitivity and SpecificityTomography, Optical CoherenceContrast MediaGold

Identifiers

PMID26987475
PMCPMC4796912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.